Skip to content

Clinical trials

Phase 3 Prostatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 3 Clear all

516 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200010
200112
200211
200319
200415
200523
200621
200722
200816
200927
201012
201116
201217
201313
201418
201513
201616
201711
201813
201913
202025
202120
202215
202325
202415
202521
202623

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed269
Recruiting66
Active, not recruiting61
Terminated51
Unknown status40
Withdrawn15
Not yet recruiting11
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radiation Therapy Oncology Group20
Ferring Pharmaceuticals18
Alliance for Clinical Trials in Oncology17
AstraZeneca14
European Organisation for Research and Treatment of Cancer - EORTC12
UNICANCER11
Novartis Pharmaceuticals9
Pfizer9
SWOG Cancer Research Network9
Sanofi9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms516
Neoplasms35
Neoplasm Metastasis25
Breast Neoplasms19
Pain12
Osteoporosis9
Lung Neoplasms7
Carcinoma, Non-Small-Cell Lung6
Colonic Neoplasms6
Disease6

Trials

Showing 26 to 50 of 516. Each trial links to its page on Pharma Observatory.

416 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.